New video presentation shows how health care providers use the features of ALRT’s Diabetes Management System to support patients with Type 2 Diabetes.
(October 23, 2017 -- RICHMOND, VA) Following the recent FDA clearance of the Company’s Insulin Dose Adjustment feature and release of its patent pending Predictive A1C innovation, ALR Technologies Inc. (“ALRT” or the “Company”) has released a new video presentation to show how health care providers are supported by the ALRT Diabetes Management System.
The latest video titled “Details of the ALRT Diabetes Management System” provides a tour of the ALRT diabetes management system from the perspective of a healthcare provider monitoring a group of diabetes patients under his or her care. The healthcare provider is able to view the progress and history of patient’s blood glucose date and the Predictive A1C trend for specific patients, and make decisions on adjustment of medicines within the system. ALRT provides in an integrated view, dosage information for all major diabetes medicines as well as the American Diabetes Association and American Association of Clinical Endocrinologists clinical guidelines for insulin dosage.
“Details of the ALRT Diabetes Management System” is the final video in a series of six videos released by ALRT last week, which highlight key features of the ALRT diabetes management system. To view the videos please go to the Company’s YouTube channel – www.youtube.com/ALRTechnologies.
Note to Readers: screenshots of the ALRT Diabetes Management System include names of medicines prescribed for the treatment of Type 2 Diabetes, including the following:
Metformin and Metformin extended release
Carbophage SR, Fortamet, Glucophage XR, Glumetza, Riomet
Adlyxin, Bydureon, Byetta, Tanzeum, Trulicity, Victoza
Soliqua 100-33, Xultophy
Farxiga, Invokana, Jardiance
Invokamet, Synjardy, Xigduo, Glyxambi
Amaryl, Diabeta, Glucotrol, Micronase
Amaryl M, Glucovance, Metaglip, Avandaryl, Duetact
Glufast, Prandin, Starlix
Januvia, Nesina, Onglyza, Tradjenta
Janumet, Jentadueto, Kazano, Kombiglyze XR, Glyxambi, Oseni
Actoplus Met, Avandamet, Oseni, Avandaryl, Duetact
Humulin N, Novolin N
Basaglar, Lantus, Levemir, Toujeo, Tresiba
Humalog Mix 50/50, Humalog Mix 75/25, Humulin 70/30, Novolin 70/30, Novolog Mix 70/30
Afrezza, Apidra, Flasp, Humalog, Novolog
Humulin R, Novolin R
ALR Technologies is a medical device company providing an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters. The System processes and streamlines collected data to support clinicians and caregivers to improve patient outcomes and assist health plans to optimize their investments in chronic disease care. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data. More information about ALR Technologies, Inc. can be found at www.alrt.com.